NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
Asan Medical Center
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Hokuriku-Kinki Immunochemotherapy Study Group
Asan Medical Center
Tokyo Metropolitan Oncology Group
Japan Clinical Cancer Research Organization
Hokkaido Gastrointestinal Cancer Study Group